HUP9903375A2 - Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények - Google Patents

Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények

Info

Publication number
HUP9903375A2
HUP9903375A2 HU9903375A HUP9903375A HUP9903375A2 HU P9903375 A2 HUP9903375 A2 HU P9903375A2 HU 9903375 A HU9903375 A HU 9903375A HU P9903375 A HUP9903375 A HU P9903375A HU P9903375 A2 HUP9903375 A2 HU P9903375A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
synergistic pharmaceutical
containing olanzapine
analgetic
Prior art date
Application number
HU9903375A
Other languages
English (en)
Inventor
Harlan E. Shannon
Daniel E. Womer
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Priority to HU9903375A priority Critical patent/HUP9903375A3/hu
Publication of HUP9903375A2 publication Critical patent/HUP9903375A2/hu
Publication of HUP9903375A3 publication Critical patent/HUP9903375A3/hu

Links

Abstract

A szabadalőm tárgya gyógyszerkészítmény, amely (I) képletű őlanzapintvagy gyógyászatilag elfőgadható sóját, és egy vagy többfájdalőmcsillapító hatóanyagőt tartalmaz. A találmány szerintikészítmény szinergista hatású. ŕ
HU9903375A 1997-03-24 1997-03-24 Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs HUP9903375A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903375A HUP9903375A3 (en) 1997-03-24 1997-03-24 Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9903375A HUP9903375A3 (en) 1997-03-24 1997-03-24 Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs

Publications (2)

Publication Number Publication Date
HUP9903375A2 true HUP9903375A2 (hu) 2000-02-28
HUP9903375A3 HUP9903375A3 (en) 2000-04-28

Family

ID=89999557

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903375A HUP9903375A3 (en) 1997-03-24 1997-03-24 Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs

Country Status (1)

Country Link
HU (1) HUP9903375A3 (hu)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10792254B2 (en) 2013-12-17 2020-10-06 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10959958B2 (en) 2014-10-20 2021-03-30 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10639281B2 (en) 2013-08-12 2020-05-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10792254B2 (en) 2013-12-17 2020-10-06 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US10959958B2 (en) 2014-10-20 2021-03-30 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form

Also Published As

Publication number Publication date
HUP9903375A3 (en) 2000-04-28

Similar Documents

Publication Publication Date Title
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
IL108007A (en) USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUT75648A (en) 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
IL133784A (en) Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
HUP9802795A3 (en) Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
IL116539A0 (en) Compositions for transdermal delivery of acid-labile drugs
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
BG106548A (en) Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog
HUP9903375A2 (hu) Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények
EP0744176A3 (en) Methods for inhibiting bone loss
HU9400290D0 (en) Pharmaceutical composition for preventing and treating retinal dieases
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage